THE METABOLISM OF TRIAZENE ANTITUMOR DRUGS

被引：27

作者：

GESCHER, A

THREADGILL, MD

机构：

来源：

PHARMACOLOGY & THERAPEUTICS | 1987年 / 32卷 / 02期

关键词：

D O I：

10.1016/0163-7258(87)90059-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：191 / 205

页数：15

共 74 条

[1] SINGLE CRYSTAL STUDIES OF CHEMOTHERAPEUTIC AGENTS .I. STRUCTURE OF 1-(2-CHLOROETHYL)-3-(5-CARBAMOYLIMIDAZOL-4-YL)-DELTA2-1,2,3-TRIAZOLINIUM CHLORIDE [J].

ABRAHAM, DJ ;

RUTHERFORD, JS ;

ROSENSTEIN, RD .

JOURNAL OF MEDICINAL CHEMISTRY, 1969, 12 (01) :189-+

[2]

AIGNER K, 1983, ANTICANCER RES, V3, P87

[3] STUDIES ON MECHANISM OF ACTION OF TUMOR INHIBITORY TRIAZENES [J].

AUDETTE, RCS ;

CONNORS, TA ;

MANDEL, HG ;

MERAI, K ;

ROSS, WCJ .

BIOCHEMICAL PHARMACOLOGY, 1973, 22 (15) :1855-1864

[4]

BLISS EA, 1987, IN PRESS J CHEM SOC

[5] PHARMACOKINETICS OF DACARBAZINE (DTIC) AND ITS METABOLITE 5-AMINOIMIDAZOLE-4-CARBOXAMIDE (AIC) FOLLOWING DIFFERENT DOSE SCHEDULES [J].

BREITHAUPT, H ;

DAMMANN, A ;

AIGNER, K .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (02) :103-109

[6] PLASMA AND TISSUE DISPOSITION OF MITOZOLOMIDE IN MICE [J].

BRINDLEY, CJ ;

ANTONIW, P ;

NEWLANDS, ES .

BRITISH JOURNAL OF CANCER, 1986, 53 (01) :91-97

[7]

BURCHENAL JH, 1956, P SOC EXP BIOL MED, V91, P398

[8] TRIAZENE DRUG METABOLITES - BASE-CATALYZED FORMATION OF N-ALKYLTRIAZENES FROM N-HYDROXYMETHYL-N-ALKYLTRIAZENES [J].

CHENG, SC ;

FERNADES, L ;

ILEY, J ;

ROSA, E .

TETRAHEDRON LETTERS, 1985, 26 (12) :1557-1560

[9]

CLARKE DA, 1955, P SOC EXP BIOL MED, V90, P484

[10] TUMOR INHIBITORY TRIAZENES - STRUCTURAL REQUIREMENTS FOR AN ACTIVE METABOLITE [J].

CONNORS, TA ;

GODDARD, PM ;

MERAI, K ;

ROSS, WCJ ;

WILMAN, DEV .

BIOCHEMICAL PHARMACOLOGY, 1976, 25 (03) :241-246

← 1 2 3 4 5 6 7 8 →